Background: The measurement of immunoglobulin E (IgE) in serum is widely used in the diagnosis of allergic reactions and parasitic infections. We describe here a fully automated assay for human IgE suitable for routine application in a general chemistry analyzer. Methods: We used an ILab 900 ® analyzer. This instrument automates a particle-enhanced immunoturbidimetric assay with an analysis time of 9 min. Results: The assay was linear in the range 4 -1000 kIU/L (r ‫؍‬ 0.9998). The intra-and interassay CVs at 57, 235, and 434 kIU/L were <3.5% and <7.4%, respectively. The detection limit was 4 kIU/L. Hemoglobin (<16 g/L), bilirubin (<250 mol/L), and myeloma paraproteins did not interfere with the assay. The assay showed good correlation with a microparticle enzyme immunoassay (r ‫؍‬ 0.998) with a mean difference between methods of ؊6 ؎ 26 kIU/L. Conclusion: The new automated serum assay for IgE is an attractive alternative that avoids the need for dedicated instrumentation.
Immunoglobulin (Ig) 1 E is an antibody involved in the reactions of allergic disease and parasitic infections (1 ) . Several methods for measuring total serum IgE have been reported. These include competitive binding assays (2 ) , ELISA (3 ), microparticle enzyme immunoassay (MEIA) (4 ) , and time-resolved fluoroimmunoassays (5 ) . These methods fulfill the rigorous requirements for sensitivity and specificity that permit the detection of microgram per liter concentrations of IgE even in the presence of gram per liter concentrations of IgG, IgM, and IgA. However, they are often time-consuming and need special, often dedicated, instruments. Conversely, turbidimetric immu-noassay is a well-established technique for the rapid quantification of analytes at gram per liter concentrations (6 ) and is widely used for the measurement of immunoglobulins other than IgE. The concentration range for turbidimetric assays may be extended by using the lightscattering properties of the immunoaggregates obtained by attaching the antibody to latex particles, termed particle-enhanced turbidimetric immunoassay (PETIA) (7) (8) (9) (10) . These techniques do not require specific instruments, merely a general automated analyzer, and have the advantages of decreased operating time and reduced costs together with an overall integration with other clinical chemistry analyses. Here we describe a PETIA for the measurement of IgE adapted for use in an ILab ® automatic analyzer, and compare it with a well-established MEIA.
Materials and Methods apparatus
IgE measurements were performed in an ILab 900, an automated, random-access, discrete clinical chemistry analyzer (Instrumentation Laboratories). This instrument facilitates the performance of spectrophotometric and turbidimetric reactions at 37°C, using one or two reagents, in bar-code primary tubes. Up to 50 different techniques can be processed simultaneously on-line in the same sample. For comparison studies, we used the MEIA technique from Abbott Diagnostics in an IMx ® immunoassay automatic analyzer (Abbott). The analyzer is a batch immunoassay system capable of producing 40 results per hour following an initial delay of 30 -50 min. The MEIA technique is a type of enzyme immunoassay in which the sample reacts with antibody-coated latex microparticles; after incubation at 34°C, the bound and unbound components are separated using a glass-fiber matrix (11 ) . 
reagents and procedures
The IgE PETIA was performed with commercial reagents obtained from Biokit (Quantex IgE kit; Biokit S.A.). The assay required two reagents. In the first step, 5 L of serum was diluted with 200 L of 0.05 mol/L glycine buffer (pH 8.3) and incubated for 3.4 min. In the second step, the diluted sample was reacted with a suspension of 100 L of polystyrene latex particles of uniform size coated with anti-human IgE monoclonal antibody. The resulting agglutination was read at 570 nm twice, at 36 s and at 5.4 min after the addition of the latex reagent. Both reagents are liquid and do not require any preparation before the analysis. MEIA technique was performed according to the manufacturer's instructions.
calibrators and control materials
The five human liquid calibrators (Quantex IgE Standard multipoint; Biokit) were between 50 and 1000 kIU/L and were traceable to the WHO 2nd International Reference Preparation of Human Serum IgE (75/502).
Control levels 1 (IgE, 55 Ϯ 7 kIU/L) and 3 (IgE, 430 Ϯ 43 kIU/L) were from Biokit. Control 2 was the Immunoassay Control, level 2 (228 Ϯ 23 kIU/L) from Dade ® . Three pools of sera were also used for performance studies and were designated as "low" (19 Ϯ 1 kIU/L), "medium" (289 Ϯ 3 kIU/L), and "high" (866 Ϯ 7 kIU/L). The sera were obtained from routine clinical samples, mixed, and frozen. When required they were thawed, mixed gently for 20 min on a Coulter mixer (Coulter Electronics), and assayed 20 times by the MEIA technique.
samples For comparison purposes, blood samples were obtained from 117 patients referred to the Clinical Laboratory of Hospital Universitari de Sant Joan de Reus. We chose samples from patients with a range of clinical conditions to include low, normal, and high concentrations of serum IgE. Blood was allowed to clot at 37°C, and serum was obtained by centrifugation at 1000g for 10 min and processed the same day. All procedures were in accordance with the ethics standards of our Institution, in which anonymity of data was guaranteed.
statistical methods
Data are presented as means Ϯ SD. Mean values for IgE by the two methods were compared by the Student t-test. Statistical significance was set at P Ͻ0.05. The association between variables was measured by linear regression analysis. The degree of agreement between both methods of measurement was estimated by the Bland-Altman graphical procedure (12 ) . Statistical calculations were performed with the SPSS statistical program (13 ) .
Results

performance evaluation of IgE measurement
Calibration curves and kinetics. Changes in the turbidity of calibrators are shown in Fig. 1 . We observed no significant changes in the calibration curves over 10 consecutive calibrations. Kinetic studies for a 1000 kIU/L calibrator, a high serum sample, and a reagent blank are shown in Fig.  2 . The best-fit model (r Ն0.996) for these curves was quadratic (curves with the general model: y ϭ b 0 ϩ b 1 x ϩ b 2 x 2 ). The upper limit of the assay was set at 1000 kIU/L. Samples with higher IgE values were automatically flagged and diluted (1:3) by the analyzer.
Imprecision. Intraassay imprecision was determined with 20 replicate analyses of the three commercial controls. To assess interassay imprecision, aliquots of these controls stored at Ϫ20°C were analyzed over 20 consecutive days. The CV values are shown in Table 1 .
Total error. Total error was calculated by adding the systematic error and the random error as described previously (14 ) . Results were as follows: 8.5% for control 1, 4.1% for control 2, and 8.4% for control 3.
Mixing experiment. When we added 100 L of the medium pool to identical volumes of the three commercial controls, the (measured IgE/theoretical IgE) ϫ 100 for quadruplicate measurements was 104% Ϯ 3% for control 1, 99% Ϯ 2% for control 2, and 104% Ϯ 3% for control 3.
Linearity and detection limit. Linearity was assessed by quadruplicate measurements of serial dilutions of the high pool (from undiluted up to a dilution of 1:256). The regression line of observed vs expected values was: y ϭ 0.996x ϩ 2.1 (r ϭ 0.9998). To determine the detection limit, the absorbance of the reagent blank was measured 20 times, the mean Ϯ SD was calculated, and the detection limit was defined as the IgE concentration corresponding to an absorbance equal to the mean of the reagent blank value ϩ 2 SD. The detection limit thus calculated was 4 kIU/L.
Interference. The interference from triglycerides, hemoglobin, and bilirubin was assessed as described previously (15 ) . The low, medium, and high sera pools were supplemented with chylomicrons, hemoglobin, or bilirubin at various concentrations. The results are shown in Fig. 3 . There was no substantial interference from hemoglobin up to 16 g/L or from bilirubin up to 250 mol/L. Hypertriglyceridemia (triglycerides Ն5 mmol/L) increased measured IgE values, particularly in samples with low IgE concentrations, which indicates that lipemic samples should be treated in an alternative manner.
Effect of paraproteinemia. The effect of nonspecific aggregation and/or cross-reactivity from paraproteinemia on the IgE determination was assessed as described (15 ) . Serial dilutions (500 L) in physiologic saline of sera from patients with IgG, IgM, and IgA myeloma were added to identical volumes of the high pool, gently mixed on a Coulter mixer for 20 min, and analyzed, and the recovery was calculated. The measured IgE concentrations in these paraproteinemic sera were Ͻ10 kIU/L. Recovery results are shown in Table 2 and indicate that the recovery was not influenced by the paraprotein concentrations (mean recovery, 103%; range, 94 -119%). 
comparison of methods
For 117 samples, the mean values for IgE were 249 kIU/L for the turbidimetric assay and 256 kIU/L for the MEIA assay (r ϭ 0.998; S y͉x ϭ 26.0). The equation of the regression line was y ϭ 1.011x Ϫ 9.685; the SDs of the slope and the intercept were 0.007 kIU/L and 2.930 kIU/L, respectively (Fig. 4A ). The degree of agreement between methods was assessed using the Bland-Altman graphical technique (Fig. 4B ). The mean difference was Ϫ6 Ϯ 26 kIU/L. Of the eight samples with values Ͼ2 SD from the mean difference, seven had IgE concentrations Ͼ600 kIU/L, indicating a proportionally low percentage of error.
Discussion
The results for all of the performance characteristics of the PETIA were acceptable when compared with recommended values (16 ) . This adaptation may allow a much faster laboratory response (9 vs 30 min to process a single sample) because incubation times are shorter and the random access to an analyzer preempts the need to wait for a complete batch of samples to be analyzed before obtaining the results. Measurements can be performed in bar-code-labeled primary tubes, which reduces the possibility of mistakes and avoids the need to aliquot or pipette the samples into special cuvettes. IgE can be measured together with other immunoglobulins or other general chemistry tests, decreasing the total volume of blood that must be drawn from a patient, an aspect that has special relevance in children, who constitute a high percentage of patients suffering from allergies. Furthermore, in our laboratory, this method has decreased by 43% the reagent cost of performing any one, single IgE measurement. In conclusion, the present study demonstrates that this PETIA is an effective, reliable, and readily automated method for measuring IgE in serum, thus contributing substantially to reduced laboratory costs and efficient sample processing.
